Publications
- Cardiovascular effects of GLP-1 receptor agonist treatment: focus on liraglutide2015 | First Faculty of Medicine
- Serum Preadipocyte Factor-1 Concentrations in Females with Obesity and Type 2 Diabetes Mellitus: The Influence of Very Low Calorie Diet, Acute Hyperinsulinemia, and Fenofibrate Treatment2013 | First Faculty of Medicine
- Cardiovascular effects of glukagon-like peptide-1 and its agonist: more than just cardiovascularly safe antidiabetics?2012 | First Faculty of Medicine
- Antidiabetic drugs and cardiovascular risk - before and now2012 | First Faculty of Medicine
- Treatment of type 2 diabetes mellitus by GLP-1 agonists2011 | First Faculty of Medicine
- Serum concentrations of fibroblast growth factor 19 in patients with obesity and type 2 diabetes mellitus: the influence of acute hyperinsulinemia, very-low calorie diet and PPAR-alpha agonist treatment2011 | First Faculty of Medicine
- Propafenone versus amiodarone for supraventricular arrhythmias in septic shock: a randomised controlled trial2023 | First Faculty of Medicine, Third Faculty of Medicine
- Akutní stavy ve vnitřním lékařství2022 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Pilsen
- The impact of obesity on the outcome of severe SARS-CoV-2 ARDS in a high volume ECMO centre: ECMO and corticosteroids support the obesity paradox2022 | First Faculty of Medicine
- The effect of high-flow arteriovenous fistulas on systemic haemodynamics and brain oxygenation2021 | First Faculty of Medicine
Loading network view...